Candriam S.C.A. Has $1.78 Million Stake in GE HealthCare Technologies Inc. $GEHC

Candriam S.C.A. reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 19.7% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,969 shares of the company’s stock after selling 5,879 shares during the period. Candriam S.C.A.’s holdings in GE HealthCare Technologies were worth $1,775,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of GEHC. Graypoint LLC increased its position in shares of GE HealthCare Technologies by 5.7% during the first quarter. Graypoint LLC now owns 3,028 shares of the company’s stock worth $244,000 after acquiring an additional 162 shares in the last quarter. Diversify Advisory Services LLC bought a new stake in GE HealthCare Technologies during the 1st quarter worth approximately $270,000. South Dakota Investment Council raised its stake in shares of GE HealthCare Technologies by 32.8% in the first quarter. South Dakota Investment Council now owns 103,607 shares of the company’s stock worth $8,362,000 after purchasing an additional 25,597 shares during the last quarter. IFP Advisors Inc lifted its holdings in shares of GE HealthCare Technologies by 250.7% in the first quarter. IFP Advisors Inc now owns 9,620 shares of the company’s stock valued at $777,000 after purchasing an additional 6,877 shares in the last quarter. Finally, J.W. Cole Advisors Inc. boosted its position in shares of GE HealthCare Technologies by 212.2% during the first quarter. J.W. Cole Advisors Inc. now owns 11,818 shares of the company’s stock valued at $954,000 after buying an additional 8,033 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently commented on the company. Wells Fargo & Company lowered their price target on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research report on Thursday, October 30th. Evercore ISI raised their price target on shares of GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a research report on Thursday, October 30th. Citigroup cut shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their price target for the stock from $93.00 to $83.00 in a report on Tuesday, October 7th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Tuesday, November 11th. Finally, Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $86.10.

GE HealthCare Technologies Stock Down 1.1%

GEHC opened at $73.15 on Monday. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $94.80. The company’s 50-day moving average price is $75.15 and its two-hundred day moving average price is $73.75. The stock has a market cap of $33.32 billion, a price-to-earnings ratio of 15.11, a PEG ratio of 2.75 and a beta of 1.13. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The company had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. During the same quarter last year, the business posted $1.14 EPS. GE HealthCare Technologies’s quarterly revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 14th. Stockholders of record on Friday, October 24th were paid a dividend of $0.035 per share. The ex-dividend date was Friday, October 24th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.